{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:35:17Z","timestamp":1789940117213,"version":"4.0.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The efficacy of B cell-depletion therapy in rheumatoid arthritis has driven interest in understanding the mechanism. Because the decrease in autoantibodies in rheumatoid arthritis does not necessarily correlate with clinical outcome, other mechanisms may be operative. We previously reported that in proteoglycan-induced arthritis (PGIA), B cell-depletion inhibits autoreactive T cell responses. Recent studies in B cell-depletion therapy also indicate a role for B cells in suppressing regulatory mechanisms. In this study, we demonstrate that B cells inhibited both the expansion and function of T regulatory (Treg) cells in PGIA. Using an anti-CD20 mAb, we depleted B cells from mice with PGIA and assessed the Treg cell population. Compared to control Ab-treated mice, Treg cell percentages were elevated in B cell-depleted mice, with a higher proportion of CD4+ T cells expressing Foxp3 and CD25. On a per-cell basis, CD4+CD25+ cells from B cell-depleted mice expressed increased amounts of Foxp3 and were significantly more suppressive than those from control Ab-treated mice. The depletion of Treg cells with an anti-CD25 mAb concurrent with B cell-depletion therapy restored the severity of PGIA to levels equal to untreated mice. Although titers of autoantibodies did not recover to untreated levels, CD4+ T cell recall responses to the immunizing Ag returned as measured by T cell proliferation and cytokine production. Thus, B cells have the capacity to regulate inflammatory responses by enhancing effector T cells along with suppressing Treg cells.<\/jats:p>","DOI":"10.4049\/jimmunol.1101844","type":"journal-article","created":{"date-parts":[[2011,9,24]],"date-time":"2011-09-24T06:44:21Z","timestamp":1316846661000},"page":"4900-4906","source":"Crossref","is-referenced-by-count":40,"title":["B Cell Depletion Enhances T Regulatory Cell Activity Essential in the Suppression of Arthritis"],"prefix":"10.1093","volume":"187","author":[{"given":"Keith M","family":"Hamel","sequence":"first","affiliation":[{"name":"Department of Immunology\/Microbiology, Rush University Medical Center , Chicago, IL 60612"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Cao","sequence":"additional","affiliation":[{"name":"Section of Rheumatology, Department of Internal Medicine, Rush University Medical Center , Chicago, IL 60612"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Ashaye","sequence":"additional","affiliation":[{"name":"Department of Immunology\/Microbiology, Rush University Medical Center , Chicago, IL 60612"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Wang","sequence":"additional","affiliation":[{"name":"Section of Rheumatology, Department of Internal Medicine, Rush University Medical Center , Chicago, IL 60612"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dunn","sequence":"additional","affiliation":[{"name":"Biogen Idec , San Diego, CA 92122"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn R","family":"Kehry","sequence":"additional","affiliation":[{"name":"Biogen Idec , San Diego, CA 92122"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor T","family":"Glant","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Rush University Medical Center , Chicago, IL 60612"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Finnegan","sequence":"additional","affiliation":[{"name":"Department of Immunology\/Microbiology, Rush University Medical Center , Chicago, IL 60612"},{"name":"Section of Rheumatology, Department of Internal Medicine, Rush University Medical Center , Chicago, IL 60612"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"2025032410435038700_r1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"2025032410435038700_r2","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"2025032410435038700_r3","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum."},{"key":"2025032410435038700_r4","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum."},{"key":"2025032410435038700_r5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/art.21650","article-title":"Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse","volume":"54","author":"Cambridge","year":"2006","journal-title":"Arthritis Rheum."},{"key":"2025032410435038700_r6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4(+) T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"2025032410435038700_r7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.bor.0000172798.26249.fc","article-title":"Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future","volume":"17","author":"Sfikakis","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"2025032410435038700_r8","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1038\/jid.2008.172","article-title":"Rituximab exerts a dual effect in pemphigus vulgaris","volume":"128","author":"Eming","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"2025032410435038700_r9","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2007-02-068999","article-title":"Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura","volume":"110","author":"Stasi","year":"2007","journal-title":"Blood"},{"key":"2025032410435038700_r10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.4049\/jimmunol.179.2.1369","article-title":"B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity","volume":"179","author":"Yanaba","year":"2007","journal-title":"J. Immunol."},{"key":"2025032410435038700_r11","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1182\/blood-2007-11-122713","article-title":"Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis","volume":"111","author":"Saadoun","year":"2008","journal-title":"Blood"},{"key":"2025032410435038700_r12","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.4049\/jimmunol.180.7.4994","article-title":"Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity","volume":"180","author":"Hamel","year":"2008","journal-title":"J. Immunol."},{"key":"2025032410435038700_r13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.1780300211","article-title":"Proteoglycan-induced arthritis in BALB\/c mice. Clinical features and histopathology","volume":"30","author":"Glant","year":"1987","journal-title":"Arthritis Rheum."},{"key":"2025032410435038700_r14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6","article-title":"Progressive polyarthritis induced in BALB\/c mice by aggrecan from normal and osteoarthritic human cartilage","volume":"41","author":"Glant","year":"1998","journal-title":"Arthritis Rheum."},{"key":"2025032410435038700_r15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1615\/CritRevImmunol.v23.i3.20","article-title":"Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics","volume":"23","author":"Glant","year":"2003","journal-title":"Crit. Rev. Immunol."},{"key":"2025032410435038700_r16","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.4049\/jimmunol.163.10.5383","article-title":"Proteoglycan (aggrecan)-induced arthritis in BALB\/c mice is a Th1-type disease regulated by Th2 cytokines","volume":"163","author":"Finnegan","year":"1999","journal-title":"J. Immunol."},{"key":"2025032410435038700_r17","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/art.23653","article-title":"Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption","volume":"58","author":"Tunyogi-Csapo","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2025032410435038700_r18","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.4049\/jimmunol.0902907","article-title":"IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis","volume":"184","author":"Doodes","year":"2010","journal-title":"J. Immunol."},{"key":"2025032410435038700_r19","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.174.6.3781","article-title":"Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis","volume":"174","author":"O\u2019Neill","year":"2005","journal-title":"J. Immunol."},{"key":"2025032410435038700_r20","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.4049\/jimmunol.179.8.5109","article-title":"Expression of CD80\/86 on B cells is essential for autoreactive T cell activation and the development of arthritis","volume":"179","author":"O\u2019Neill","year":"2007","journal-title":"J. Immunol."},{"key":"2025032410435038700_r21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"2025032410435038700_r22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"2025032410435038700_r23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"2025032410435038700_r24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","article-title":"Regulatory T cell lineage specification by the forkhead transcription factor foxp3","volume":"22","author":"Fontenot","year":"2005","journal-title":"Immunity"},{"key":"2025032410435038700_r25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"2025032410435038700_r26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"key":"2025032410435038700_r27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J. Exp. Med."},{"key":"2025032410435038700_r28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/kel089","article-title":"Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood","volume":"45","author":"Lawson","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2025032410435038700_r29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"key":"2025032410435038700_r30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"2025032410435038700_r31","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1073\/pnas.0703642104","article-title":"Antagonistic nature of T helper 1\/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells","volume":"104","author":"Wei","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032410435038700_r32","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/eji.200838913","article-title":"IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis","volume":"39","author":"Chang","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"2025032410435038700_r33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4049\/jimmunol.0903412","article-title":"Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells","volume":"184","author":"Caretto","year":"2010","journal-title":"J. Immunol."},{"key":"2025032410435038700_r34","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"2025032410435038700_r35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"2025032410435038700_r36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI200420855","article-title":"Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease","volume":"114","author":"Olson","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2025032410435038700_r37","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.2337\/db08-1504","article-title":"CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells","volume":"58","author":"Mari\u00f1o","year":"2009","journal-title":"Diabetes"},{"key":"2025032410435038700_r38","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1172\/JCI32405","article-title":"Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice","volume":"117","author":"Hu","year":"2007","journal-title":"J. Clin. Invest."},{"key":"2025032410435038700_r39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.20051438","article-title":"B cell-deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis","volume":"203","author":"Yu","year":"2006","journal-title":"J. Exp. Med."},{"key":"2025032410435038700_r40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2006.12.006","article-title":"Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis","volume":"123","author":"Sfikakis","year":"2007","journal-title":"Clin. Immunol."},{"key":"2025032410435038700_r41","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","article-title":"Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab","volume":"112","author":"Stasi","year":"2008","journal-title":"Blood"},{"key":"2025032410435038700_r42","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/art.20180","article-title":"Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype","volume":"50","author":"Hanyecz","year":"2004","journal-title":"Arthritis Rheum."},{"key":"2025032410435038700_r43","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.4049\/jimmunol.169.6.3345","article-title":"IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms","volume":"169","author":"Finnegan","year":"2002","journal-title":"J. Immunol."},{"key":"2025032410435038700_r44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nature05543","article-title":"Foxp3-dependent programme of regulatory T-cell differentiation","volume":"445","author":"Gavin","year":"2007","journal-title":"Nature"},{"key":"2025032410435038700_r45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.immunol.24.021605.090517","article-title":"B cell immunobiology in disease: evolving concepts from the clinic","volume":"24","author":"Martin","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"2025032410435038700_r46","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.immuni.2009.04.009","article-title":"Control of regulatory T cell lineage commitment and maintenance","volume":"30","author":"Josefowicz","year":"2009","journal-title":"Immunity"},{"key":"2025032410435038700_r47","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"2025032410435038700_r48","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1126\/science.1191996","article-title":"Stability of the regulatory T cell lineage in vivo","volume":"329","author":"Rubtsov","year":"2010","journal-title":"Science"},{"key":"2025032410435038700_r49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","article-title":"Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells","volume":"30","author":"Wei","year":"2009","journal-title":"Immunity"},{"key":"2025032410435038700_r50","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.1169152","article-title":"Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer\u2019s patches","volume":"323","author":"Tsuji","year":"2009","journal-title":"Science"},{"key":"2025032410435038700_r51","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2025032410435038700_r52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann. Neurol."},{"key":"2025032410435038700_r53","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1074\/jbc.M705100200","article-title":"IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner","volume":"282","author":"Wei","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2025032410435038700_r54","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2009.10.001","article-title":"Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection","volume":"31","author":"Oldenhove","year":"2009","journal-title":"Immunity"},{"key":"2025032410435038700_r55","doi-asserted-by":"crossref","first-page":"18460","DOI":"10.1073\/pnas.0809850105","article-title":"IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells","volume":"105","author":"Korn","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032410435038700_r56","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/ar624","article-title":"CD4+CD25+ immunoregulatory T cells may not be involved in controlling autoimmune arthritis","volume":"5","author":"Bardos","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"2025032410435038700_r57","doi-asserted-by":"crossref","first-page":"16246","DOI":"10.1073\/pnas.1007422107","article-title":"Enhancement of antigen-specific Treg vaccination in vivo","volume":"107","author":"Daniel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032410435038700_r58","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.4049\/jimmunol.1000820","article-title":"Cellular requirements for diabetes induction in DO11.10xRIPmOVA mice","volume":"185","author":"Wesley","year":"2010","journal-title":"J. Immunol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/187\/9\/4900\/61689374\/1101844.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/187\/9\/4900\/61689374\/1101844.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T05:49:31Z","timestamp":1743140971000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/187\/9\/4900\/7989814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,11,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1101844","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,11]]},"published":{"date-parts":[[2011,11,1]]}}}